J. Margison
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
Papers in
-
- Renal and related cancers 2
- Glutathione Transferases and Polymorphisms 1
-
- Chemotherapy-induced organ toxicity mitigation 6
- Co-authors
- Geoffrey P. Margison (4 shared papers)Malcolm Ranson (3 shared papers)Ruggero Montesano (3 shared papers)Gavin Halbert (1 shared paper)M Brampton (1 shared paper)Valery Yu. Alakhov (1 shared paper)David J. Kerr (1 shared paper)D. Ferry (1 shared paper)
- Journals
- Biochemical Journal (3 papers)Cancer Chemotherapy and Pharmacology (3 papers)British Journal of Cancer (2 papers)Journal of Cancer Research and Clinical Oncology (2 papers)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- United KingdomFranceGermany
In The Last Decade
J. Margison
15 papers receiving 793 citations
Peers
Comparison fields: 5 of 80
- Biomaterials 377
- Pharmaceutical Science 69
- Cancer Research 102
- Oncology 171
- Molecular Biology 330
Countries citing papers authored by J. Margison
This map shows the geographic impact of J. Margison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Margison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Margison more than expected).
Fields of papers citing papers by J. Margison
This network shows the impact of papers produced by J. Margison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Margison. The network helps show where J. Margison may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Margison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 332 | |
| 2 | 2006 | 134 | |
| 3 | 1976 | 90 | |
| 4 | 1989 | 63 | |
| 5 | 2001 | 39 | |
| 6 | 1977 | 37 | |
| 7 | 1977 | 35 | |
| 8 | 1996 | 26 | |
| 9 | 1986 | 25 | |
| 10 | 1990 | 21 | |
| 11 | 1990 | 15 | |
| 12 | 1991 | 14 | |
| 13 | 1979 | 10 | |
| 14 | 1994 | 9 | |
| 15 | 1986 | 2 |
About J. Margison
J. Margison is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Occupational Therapy, Oncology and Cardiology and Cardiovascular Medicine, having authored 15 papers that have together received 852 indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (6 papers), Safe Handling of Antineoplastic Drugs (4 papers), Lung Cancer Research Studies (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Renal and related cancers (2 papers), Carcinogens and Genotoxicity Assessment (2 papers), Glutathione Transferases and Polymorphisms (1 paper) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Biomaterials (377 citations), Pharmaceutical Science (69 citations), Cancer Research (102 citations), Oncology (171 citations) and Molecular Biology (330 citations). J. Margison has collaborated with scholars based in United Kingdom, France and Germany. Frequent co-authors include Geoffrey P. Margison, Malcolm Ranson, Ruggero Montesano, Gavin Halbert, M Brampton, Valery Yu. Alakhov, David J. Kerr, D. Ferry, Sarah Danson and Nicholas Thatcher. Their work appears in journals such as Biochemical Journal, Cancer Chemotherapy and Pharmacology, British Journal of Cancer, Journal of Cancer Research and Clinical Oncology and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.